MOSUNETUZUMAB vs MUPIROCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MOSUNETUZUMAB vs MUPIROCIN: Safety Overview
| Metric | MOSUNETUZUMAB | MUPIROCIN |
|---|---|---|
| Total FAERS Reports | 506 | 3,459 |
| Deaths Reported | 96 | 32 |
| Death Rate | 19.0% | 0.9% |
| Hospitalizations | 328 | 352 |
| Average Patient Age | 65.0 yrs | 58.6 yrs |
| % Female Patients | 43.7% | 79.7% |
| FDA Approval Date | N/A | Apr 27, 2020 |
| Manufacturer | Genentech, Inc. | Alembic Pharmaceuticals Limited |
| Route | SUBCUTANEOUS | TOPICAL |
| Marketing Status | N/A | Discontinued |